Cilostazol
Noclaud contains the active ingredient cilostazol and belongs to a group of medicines called phosphodiesterase type 3 inhibitors. It has various effects, including the dilation of certain blood vessels and the reduction of the activity of blood clotting (aggregation) of certain blood cells, called platelets, within blood vessels.
Noclaud has been prescribed to treat "intermittent claudication". Intermittent claudication is a cramp-like pain in the lower limbs that occurs during walking and is caused by insufficient blood flow to the legs. Noclaud increases the distance that the patient can walk without experiencing pain by improving blood circulation in the lower limbs.
Cilostazol is recommended only for patients who have not had sufficient relief from symptoms after lifestyle modifications (including quitting smoking and increasing exercise intensity) and other appropriate interventions. It is essential for the patient to continue making lifestyle modifications while being treated with cilostazol.
Before starting to take Noclaud, discuss it with your doctor or pharmacist:
During treatment with Noclaud
Noclaud is not intended for children.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, and about medicines you plan to take.
In particular, inform your doctor about taking certain medicines that are usually used to treat pain and/or inflammation of muscles or joints and medicines that reduce blood clotting. These include:
If such medicines are taken together with Noclaud, the doctor may perform certain routine blood tests.
Some medicines taken at the same time as Noclaud may interfere with its action. They may enhance the side effects of Noclaud or reduce its effectiveness. Noclaud may similarly affect other medicines. Before starting to take Noclaud, inform your doctor about taking:
In case of doubt, whether the above applies to the medicines you are taking, consult your doctor or pharmacist.
Before starting to take Noclaud, inform your doctor if you are taking medicines for high blood pressure, as Noclaud may cause additional blood pressure-lowering effects. If excessive blood pressure lowering occurs, it may lead to rapid heartbeat. These medicines include:
It may be possible to continue taking these medicines together with Noclaud, and the doctor will be able to decide what treatment is suitable for you.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Noclaud MUST NOTbe taken during pregnancy.
IT IS NOT RECOMMENDEDto take Noclaud while breastfeeding.
Noclaud may cause dizziness. If you experience dizziness after taking Noclaud, DO NOTdrive, DO NOTuse tools, and DO NOToperate any machinery. Inform your doctor or pharmacist.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, consult your doctor or pharmacist.
Some benefits of taking Noclaud may be noticeable after 4-12 weeks of treatment.
The doctor will assess the effectiveness after 3 months of treatment and may recommend stopping cilostazol treatment if the therapy is not effective enough.
Noclaud is not intended for children.
If for any reason you have taken more Noclaud tablets than you should, you may experience objective and subjective symptoms such as severe headaches, diarrhea, low blood pressure, and irregular heartbeat.
If you have taken more tablets than the prescribed dose, contact your doctor or local hospital immediately. Remember to take the packaging with you so that it is clear what medicine has been taken.
There is no need to worry if you miss a dose. Wait and take the next dose at the right time, and then take the medicine as recommended. DO NOTtake a double dose to make up for the missed tablet.
If you stop taking Noclaud, the pain in your lower limbs may return or worsen.
Therefore, only stop taking Noclaud if you experience side effects that require urgent medical attention (see section 4) or if your doctor tells you to.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Noclaud can cause side effects, although not everybody gets them.
If you experience any of the following side effects, you may need urgent medical attention. Stop taking Noclaud and contact your doctor or go to the nearest hospital.
You should also tell your doctor immediately if you experience fever or sore throat.
It may be necessary to perform certain blood tests, and the doctor will decide on further treatment.
Very common side effects(may affect more than 1 in 10 people)
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
In people with diabetes, there may be a higher risk of bleeding into the eye.
Rare side effects(may affect up to 1 in 1000 people)
During treatment with cilostazol, the following side effects have been reported, but their frequency is unknown(frequency cannot be estimated from the available data);
If any of the side effects get worse, tell your doctor or pharmacist.
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
There are no special storage instructions.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Do not use this medicine if you notice visible signs of deterioration (e.g., discoloration).
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Appearance:
Odorless or almost odorless, white or almost white, round, flat tablets with beveled edges. The tablets have a stylized letter E and the number 602 embossed on one side, and no markings on the other side.
Packaging:
28 (2 x 14) or 56 (4 x 14) tablets in PVC/PVDC/Al blisters in a cardboard box, with a patient information leaflet.
For more detailed information, contact the marketing authorization holder or the parallel importer.
Egis Pharmaceuticals PLC
Keresztúri út 30-38.
1106 Budapest
Hungary
Egis Pharmaceuticals PLC
Bökényföldi út 118-120.
1165 Budapest
Hungary
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in the Czech Republic, the country of export:83/149/14-C
Parallel import authorization number:98/20
Hungary
Noclaud 100 mg tablet
Czech Republic
Noclaud
Latvia
Sollazon 100 mg tablets
Lithuania
Sollazon 100 mg tablets
Poland
Noclaud
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.